CRMD RSI Chart
Last 7 days
2.9%
Last 30 days
18.4%
Last 90 days
4.5%
Trailing 12 Months
1.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 0 | 0 | 0 | 0 |
2022 | 92.3K | 170.2K | 248.1K | 326.0K |
2021 | 253.4K | 245.2K | 190.3K | 14.4K |
2020 | 193.6K | 174.8K | 208.3K | 239.2K |
2019 | 570.3K | 598.0K | 285.0K | 283.3K |
2018 | 313.0K | 184.4K | 495.8K | 429.8K |
2017 | 222.2K | 341.9K | 358.5K | 329.3K |
2016 | 220.3K | 116.8K | 125.3K | 224.1K |
2015 | 208.3K | 288.6K | 272.1K | 210.1K |
2014 | 0 | 0 | 0 | 189.3K |
2013 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 13, 2024 | todisco joseph | bought | 50,718 | 3.74 | 13,561 | chief executive officer |
Jan 12, 2024 | masson-hurlburt elizabeth | acquired | - | - | 50,000 | evp, head of clinical ops. |
Jan 12, 2024 | mistry erin | sold (taxes) | -15,229 | 3.47 | -4,389 | chief commercial officer |
Jan 12, 2024 | todisco joseph | acquired | - | - | 133,333 | chief executive officer |
Jan 12, 2024 | mistry erin | acquired | - | - | 50,000 | chief commercial officer |
Jan 12, 2024 | todisco joseph | sold (taxes) | -47,820 | 3.47 | -13,781 | chief executive officer |
Jan 12, 2024 | david matthew t | sold (taxes) | -18,099 | 3.47 | -5,216 | chief financial officer |
Jan 12, 2024 | masson-hurlburt elizabeth | sold (taxes) | -15,972 | 3.47 | -4,603 | evp, head of clinical ops. |
Jan 12, 2024 | david matthew t | acquired | - | - | 50,000 | chief financial officer |
Dec 15, 2023 | dunton alan w | bought | 9,900 | 3.3 | 3,000 | - |
Which funds bought or sold CRMD recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | new | - | 68.00 | 68.00 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 6.59 | 815,491 | 10,623,300 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 72.63 | 119,801 | 278,616 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | added | 4.98 | 6,438 | 102,719 | -% |
Feb 26, 2024 | Virtu Financial LLC | new | - | 103,000 | 103,000 | 0.01% |
Feb 16, 2024 | HARBOUR INVESTMENTS, INC. | unchanged | - | 3.00 | 188 | -% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | unchanged | - | 1,000 | 46,000 | -% |
Feb 16, 2024 | GSA CAPITAL PARTNERS LLP | new | - | 93,000 | 93,000 | 0.01% |
Feb 15, 2024 | Legal & General Group Plc | added | 10.88 | 2,612 | 23,222 | -% |
Feb 15, 2024 | Farther Finance Advisors, LLC | new | - | 399 | 399 | -% |
Unveiling CorMedix Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to CorMedix Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
CorMedix Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 |
Revenue | -100.0% | - | 290,310 | 6,817 | 21,253 | 7,636 | 22,862 | 38,088 | 8,191 | 88,261 | 55,714 | 93,020 | 16,443 | 74,054 | 24,778 | 59,530 | 35,266 | 163,692 | 26,523 | 372,514 | 7,550 | 23,210 |
Cost Of Revenue | -100.0% | - | 406 | 1,469 | 332 | 1,527 | 48,007 | 25,166 | 14,426 | 61,339 | 57,232 | 79,913 | 19,184 | 48,517 | 46,125 | 79,026 | 21,128 | 226,955 | 22,114 | 312,434 | 33,663 | 28,575 |
Gross Profit | -100.0% | - | 29,296 | 5,348 | 20,921 | 6,109 | 8,390 | 12,922 | -6,235 | 26,922 | -1,518 | 13,107 | -2,741 | 25,537 | -21,347 | -19,496 | 14,138 | -63,263 | 4,409 | 60,080 | -26,112 | -5,365 |
Operating Expenses | 86.1% | 15,668,744 | 8,418,524 | 6,967,282 | 8,261,366 | 7,038,470 | 7,788,310 | 8,577,841 | 5,875,993 | 7,237,440 | 6,083,122 | 6,616,862 | 8,917,868 | 5,637,285 | 5,354,477 | 5,152,019 | 5,551,494 | 4,859,918 | -2,133,822 | 10,301,533 | 8,546,038 | 10,183,458 |
S&GA Expenses | 140.0% | 13,379,855 | 5,575,302 | 4,628,014 | 5,051,895 | 4,750,883 | 4,553,091 | 3,836,613 | 3,355,790 | 4,601,108 | 3,788,693 | 3,691,507 | 3,232,576 | 3,165,168 | 2,677,470 | 2,631,027 | 2,571,587 | 1,984,922 | 2,213,440 | 2,012,439 | 1,945,825 | 1,903,016 |
R&D Expenses | -19.5% | 2,288,889 | 2,843,223 | 2,339,268 | 3,209,471 | 2,287,587 | 3,235,219 | 4,741,228 | 2,520,203 | 2,636,332 | 2,294,429 | 2,925,355 | 5,685,292 | 2,472,117 | 2,677,008 | 2,520,992 | 2,979,907 | 2,874,996 | -4,347,261 | 8,289,094 | 6,600,213 | 8,280,442 |
EBITDA Margin | 0.0% | -94.90 | -94.88 | -126 | -178 | -305 | -1,961 | -141 | -111 | -105 | -111 | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | -25.3% | 6,556 | 8,776 | 8,776 | 3,585 | 5,378 | 5,378 | 5,381 | - | 5,184 | 5,322 | 7,800 | 13,828 | 6,276 | 6,276 | 172,429 | 306,736 | 302,048 | - | - | - | 1,873 |
Income Taxes | - | - | - | - | -585,617 | - | - | - | -1,250,186 | - | - | -3,138 | -5,169,395 | 6,276 | - | - | -5,060,778 | - | - | - | - | - |
Earnings Before Taxes | 100.0% | - | -8,208,951 | -6,853,721 | -8,190,456 | - | -7,790,987 | -8,569,366 | -5,883,121 | - | -6,086,945 | -6,600,747 | -8,951,819 | - | -5,304,185 | -5,264,847 | -5,756,936 | - | 5,412,604 | -10,236,119 | -8,556,911 | - |
EBT Margin | 0% | -95.22 | -95.22 | -126 | -178 | -306 | -1,966 | -142 | -112 | -106 | -112 | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -79.3% | -14,714,802 | -8,208,951 | -6,853,721 | -7,604,839 | -7,034,194 | -7,790,987 | -8,569,366 | -4,632,935 | -7,216,938 | -6,086,945 | -6,600,747 | -3,782,424 | -5,557,567 | -5,304,185 | -5,264,847 | -696,158 | -5,167,884 | 2,148,518 | -10,236,119 | -8,556,911 | -10,185,118 |
Net Income Margin | -55.9% | -142 | -91.11 | -118 | -182 | -303 | -1,958 | -139 | -100 | -93.46 | -92.08 | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | -75.7% | -11,041,625 | -6,283,594 | -6,071,854 | -5,471,978 | -6,748,666 | -6,498,121 | -6,281,407 | -3,097,132 | -6,703,892 | -6,010,571 | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -10.2% | 82.00 | 91.00 | 57.00 | 59.00 | 62.00 | 62.00 | 68.00 | 65.00 | 69.00 | 75.00 | 81.00 | 84.00 | 49.00 | 40.00 | 24.00 | 27.00 | 29.00 | 34.00 | 28.00 | 27.00 | 19.00 |
Current Assets | -10.8% | 79.00 | 89.00 | 55.00 | 57.00 | 60.00 | 60.00 | 65.00 | 63.00 | 66.00 | 73.00 | 80.00 | 83.00 | 48.00 | 39.00 | 24.00 | 27.00 | 29.00 | 34.00 | 27.00 | 27.00 | 19.00 |
Cash Equivalents | -17.8% | 44.00 | 53.00 | 20.00 | 25.00 | 43.00 | 43.00 | 49.00 | 46.00 | 54.00 | 67.00 | 73.00 | 76.00 | 42.00 | 35.00 | 17.00 | 12.00 | 17.00 | 20.00 | 15.00 | 18.00 | 18.00 |
Inventory | - | - | - | - | - | - | 269* | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net PPE | 17.4% | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | 44.9% | 12.00 | 8.00 | 8.00 | 5.00 | 7.00 | 6.00 | 6.00 | 5.00 | 6.00 | 6.00 | 4.00 | 4.00 | 5.00 | 6.00 | 6.00 | 6.00 | 6.00 | 5.00 | 11.00 | 11.00 | 14.00 |
Current Liabilities | 48.6% | 11.00 | 8.00 | 7.00 | 5.00 | 6.00 | 5.00 | 5.00 | 4.00 | 5.00 | 5.00 | 3.00 | 3.00 | 4.00 | 5.00 | 6.00 | 6.00 | 6.00 | 5.00 | 4.00 | 4.00 | 8.00 |
Shareholder's Equity | -15.7% | 70.00 | 83.00 | 49.00 | 54.00 | 55.00 | 56.00 | 62.00 | 60.00 | 63.00 | 69.00 | 77.00 | 80.00 | 44.00 | 34.00 | 0.00 | 0.00 | 24.00 | 29.00 | 16.00 | 17.00 | 5.00 |
Retained Earnings | -4.8% | -321 | -306 | -297 | -285 | -275 | -267 | -260 | -252 | -245 | -237 | -229 | -224 | -217 | -211 | -204 | -200 | -195 | -190 | -184 | -184 | -178 |
Additional Paid-In Capital | 0.4% | 392 | 390 | 346 | 340 | 330 | 323 | 322 | 312 | 308 | 307 | 306 | 305 | 262 | 246 | 223 | 222 | 219 | 219 | 201 | 201 | 184 |
Shares Outstanding | 0.2% | 55.00 | 55.00 | 46.00 | 44.00 | 43.00 | 40.00 | 39.00 | 38.00 | 38.00 | 38.00 | 37.00 | 36.00 | 34.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | - | 164 | - | - | - | 208 | - | - | - | 208 | - | - | - | 209 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -23.5% | -10,745 | -8,697 | -8,572 | -10,393 | -6,154 | -5,995 | -5,462 | -6,744 | -5,869 | -5,503 | -3,091 | -6,690 | -5,933 | -7,312 | -754 | -7,966 | -3,884 | -3,964 | 164 | -7,367 | -7,200 |
Share Based Compensation | 21.4% | 1,217 | 1,003 | 1,057 | 2,216 | 874 | 984 | 1,074 | 1,138 | 1,253 | 1,048 | 1,010 | 1,732 | 516 | 611 | 696 | 677 | 453 | 571 | 606 | 809 | 19.00 |
Cashflow From Investing | 201.9% | 598 | -586 | -2,385 | -14,686 | -1.86 | -114 | 594 | -4,187 | -7,129 | -1,271 | -208 | -526 | -1,847 | 3,243 | 5,045 | 985 | 296 | -477 | -3,874 | -7,964 | 109* |
Cashflow From Financing | -98.9% | 468 | 42,899 | 5,350 | 7,200 | 6,046 | 437 | 8,411 | 3,004 | - | - | 177 | 41,581 | 15,322 | 21,943 | - | 2,835 | -205 | 10,029 | 14.00 | 15,968 | 18,384 |
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Revenue: | ||
Net sales | $ 65,408 | |
Cost of sales | (3,734) | |
Gross profit | 61,674 | |
Operating Expenses: | ||
Research and development | (13,155,125) | (10,679,549) |
Selling, general and administrative | (35,802,663) | (20,006,093) |
Total operating expenses | (48,957,788) | (30,685,642) |
Loss From Operations | (48,957,788) | (30,623,968) |
Other Income (Expense): | ||
Interest income | 2,681,851 | 326,016 |
Foreign exchange transaction (loss) income | (28,994) | 37,145 |
Interest expense | (34,296) | (26,515) |
Total other income | 2,618,561 | 336,646 |
Net Loss Before Income Taxes | (46,339,227) | (30,287,322) |
Tax benefit | 585,617 | |
Net Loss | (46,339,227) | (29,701,705) |
Other Comprehensive Income (Loss): | ||
Unrealized gain from investments | 9,683 | 5,055 |
Foreign currency translation gain (loss) | 1,682 | (9,442) |
Total other comprehensive gain (loss) | 11,365 | (4,387) |
Comprehensive Loss | $ (46,327,862) | $ (29,706,092) |
Net Loss Per Common Share – Basic (in Dollars per share) | $ (0.91) | $ (0.74) |
Weighted Average Common Shares Outstanding – Basic (in Shares) | 50,902,931 | 40,274,273 |
Consolidated Balance Sheets - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 43,642,684 | $ 43,148,323 |
Restricted cash | 77,453 | 124,102 |
Short-term investments | 32,388,130 | 15,644,062 |
Inventories, net | 2,106,345 | |
Prepaid research and development expenses | 353,574 | 11,016 |
Other prepaid expenses and current assets | 882,214 | 623,672 |
Total current assets | 79,450,400 | 59,551,175 |
Property and equipment, net | 1,866,224 | 1,609,679 |
Restricted cash, long term | 103,055 | 102,320 |
Operating lease right-of-use assets | 640,278 | 775,085 |
TOTAL ASSETS | 82,059,957 | 62,038,259 |
Current liabilities | ||
Accounts payable | 4,279,679 | 2,202,149 |
Accrued expenses | 6,970,217 | 3,973,941 |
Operating lease liabilities, short-term | 150,619 | 134,801 |
Total current liabilities | 11,400,515 | 6,310,891 |
Operating lease liabilities, net of current portion | 517,013 | 667,632 |
TOTAL LIABILITIES | 11,917,528 | 6,978,523 |
COMMITMENTS AND CONTINGENCIES (Note 6) | ||
STOCKHOLDERS’ EQUITY | ||
Preferred stock - $0.001 par value: 2,000,000 shares authorized; 181,622 shares issued and outstanding at December 31, 2023 and 2022 | 182 | 182 |
Common stock - $0.001 par value: 160,000,000 shares authorized at December 31, 2023 and 2022; 54,938,258 and 42,815,196 shares issued and outstanding at December 31, 2023 and 2022, respectively | 54,938 | 42,815 |
Accumulated other comprehensive gain | 94,108 | 82,743 |
Additional paid-in capital | 391,693,214 | 330,294,782 |
Accumulated deficit | (321,700,013) | (275,360,786) |
TOTAL STOCKHOLDERS’ EQUITY | 70,142,429 | 55,059,736 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 82,059,957 | $ 62,038,259 |